Evidence map›Paper›PMID 11773268›Full record

ArticleJournal of the National Cancer Institute2002

Prostate cancer in bone: importance of context for inhibition of matrix metalloproteinases.

Mina J Bissell, Johanne Le Beyec, Robin L Anderson

Abstract readCommentEditorial
In one paragraph

Article in Journal of the National Cancer Institute, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Assessment of the potential of pathological stains in human prostate cancer.Journal of clinical and diagnostic research : JCDR · 2014
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Mina J Bissell
Johanne Le Beyec
Robin L Anderson

Funding

Systems-Based Predictions of Responses to Cancer TherapyU54CA112970 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI SPELLMAN, PAUL T. · 2004 to 2014
$27.1M
TRANS-NETWORK PROJECTSU54CA143836 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI LIPHARDT, JAN T. · 2009 to 2014
$15.1M
Role of Metalloproteinases in Mammary Gland RemodelingR01CA057621 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WERB, ZENA · 1993 to 2017
$9.0M
Definition of the Microenvironment in Breast CancerR01CA064786 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI BISSELL, MINA · 1995 to 2020
$6.1M
Myoepithelial cell differentiation defects in ductal carcinoma in situ (DCIS)U01CA143233 · NCI · DANA-FARBER CANCER INST · PI BISSELL, MINA, POLLARD, JEFFREY W. · 2009 to 2013
$2.5M
Bioengineering 3-D Models for Organ-Specific Cancer Therapy in Lung and BreastU54CA126552 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI BISSELL, MINA · 2006 to 2010
$2.2M
NCI NIH HHS R01 CA057621NCI NIH HHS R01 CA064786NCI NIH HHS U01 CA143233NCI NIH HHS U54 CA112970NCI NIH HHS U54 CA126552NCI NIH HHS U54 CA143836
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Matrix Metalloproteinase InhibitorsNeoplasm MetastasisAnimalsAntineoplastic AgentsBone NeoplasmsDisease Models, AnimalHumansMalePhenylalanineProstatic NeoplasmsThiophenesAntineoplastic AgentsbatimastatMatrix Metalloproteinase InhibitorsPhenylalanineThiophenes

Identifiers

PMID11773268
PMCPMC3027556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.